Adverum Biotechnologies I... (ADVM)
4.16
-0.55 (-11.68%)
At close: Mar 03, 2025, 3:59 PM
4.16
0.00%
After-hours: Mar 03, 2025, 04:00 PM EST
Adverum Biotechnologies Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -117.17M | -154.54M | -145.54M | -117.51M | -64.49M | -72.63M | -56.15M | -113.75M | -47.45M | -25.4M | -5.28M | -1.81M |
| Depreciation & Amortization | 5.64M | 6.53M | 4.64M | 4.16M | 1.57M | 1.75M | 2.1M | 1.6M | 812K | 162K | 26K | 1K |
| Stock-Based Compensation | 17.57M | 20.08M | 25.19M | 20.39M | 9.9M | 13.43M | 8.72M | 11.42M | 11.51M | 8.57M | 515K | 76K |
| Other Working Capital | -7.95M | 19.04M | 5.67M | 11.14M | 5.71M | -1.55M | -1.95M | 3.29M | -2.11M | 7.76M | 8K | 25K |
| Other Non-Cash Items | 11.37M | -51K | -25K | 75K | 58K | 6.35M | 70K | 8K | 218K | 18K | 885K | 16K |
| Deferred Income Tax | n/a | n/a | 3.83M | 863K | -1.27M | -1.25M | 593K | 60.71M | 801K | 963K | 1.75M | -19K |
| Change in Working Capital | -8.32M | 19.89M | 4.06M | 12.73M | 5.06M | -1.62M | -756K | 1.64M | -1.22M | 10.05M | -70K | 470K |
| Operating Cash Flow | -90.9M | -108.09M | -107.83M | -79.29M | -49.17M | -53.96M | -45.42M | -38.37M | -35.34M | -5.65M | -2.17M | -1.27M |
| Capital Expenditures | -808K | -11.82M | -15.12M | -11.84M | -19.25M | -809K | -1.02M | -2.41M | -2.99M | -943K | -91K | -3K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.45M | n/a | n/a | n/a | n/a |
| Purchase of Investments | -36.72M | -104.36M | -407.51M | -570.39M | -197.34M | -78.73M | -209.79M | -38.77M | -88.43M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 134.4M | 257.9M | 501.35M | 302.06M | 148.52M | 148.98M | 88.6M | 37.74M | 49.85M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 38.77M | n/a | n/a | n/a | n/a |
| Investing Cash Flow | 96.88M | 141.72M | 78.71M | -280.17M | -68.07M | 69.44M | -122.2M | 38.77M | -41.57M | -943K | -91K | -3K |
| Debt Repayment | n/a | n/a | -240K | -61K | -112K | -175K | n/a | n/a | n/a | 2M | 1.5M | 500K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4M | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 69K | 607K | 952K | 11.74M | 2.41M | -63K | 229K | 556K | -94K | 46.99M | 980K | n/a |
| Financial Cash Flow | 69K | 607K | 2.4M | 355.99M | 28.19M | 69.95M | 16.75M | 556K | 138.86M | 165.44M | 2.48M | 500K |
| Net Cash Flow | 6.04M | 34.24M | -26.73M | -3.47M | -89.05M | 85.43M | -151.65M | 822K | 61.94M | 158.84M | 207K | -761K |
| Free Cash Flow | -91.71M | -119.91M | -122.95M | -91.14M | -68.42M | -54.77M | -46.44M | -40.78M | -38.33M | -6.59M | -2.27M | -1.27M |